Corino Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.corinorx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Corino Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03633591
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
News
No news found